Cell states and neighborhoods in distinct clinical stages of primary and metastatic esophageal adenocarcinoma
Preprint
Abstract
Esophageal adenocarcinoma (EAC) is a highly lethal cancer of the upper gastrointestinal tract with rising incidence in western populations. To decipher EAC disease progression and therapeutic response, we performed multiomic analyses of a cohort of primary and metastatic EAC tumors, incorporating single-nuclei transcriptomic and chromatin accessibility sequencing, along with spatial profiling. We identified tumor microenvironmental features previously described to associate with therapy response. We identified five malignant cell programs, including undifferentiated, intermediate, differentiated, epithelial-to-mesenchymal transition, and cycling programs, which were associated with differential epigenetic plasticity and clinical outcomes, and for which we inferred candidate transcription factor regulons. Furthermore, we revealed diverse spatial localizations of malignant cells expressing their associated transcriptional programs and predicted their significant interactions with microenvironmental cell types. We validated our findings in three external single-cell RNA-seq and three bulk RNA-seq studies. Altogether, our findings advance the understanding of EAC heterogeneity, disease progression, and therapeutic response.Keywords
All Related Versions
- Published version: Cell Reports Medicine, 6 (6), 102188.
This publication has 113 references indexed in Scilit:
- Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinomaCancer Cell, 2023
- Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progressionCancer Cell, 2023
- Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinomaCancer Cell, 2021
- Epigenomic State Transitions Characterize Tumor Progression in Mouse Lung AdenocarcinomaCancer Cell, 2020
- Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell CarcinomaCell, 2020
- Intratumor Heterogeneity: The Rosetta Stone of Therapy ResistanceCancer Cell, 2020
- An Integrative Model of Cellular States, Plasticity, and Genetics for GlioblastomaCell, 2019
- An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome AnalyticsCell, 2018
- The Human Transcription FactorsCell, 2018
- A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer MetastasisCancer Cell, 2014